Baxter International Inc., founded in 1931, is developing, producing and delivering medical devices, pharmaceutical and biotechnology products crucial for the care of patientswith hemophilia, immune system disorders, cancer, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions, allowing them to achieve and sustain a high quality of life.
In Greece since 1990, Baxter is supporting healthcare professionals and patients, through therapies for complex, chronic and acute conditions. With a new direct-sales functional and business model that ensures patient access to critical treatments, as well as a strategic focus on homecare, Baxter aims to be positioned as a credible partner in efforts to improve the current healthcare system. More information at www.baxter.gr
